Key result
Multimodality imaging and clinical red flags distinguish hypertrophic cardiomyopathy from its mimicking phenocopies.
Answers are grounded in this paper and cite their sources.
This review outlines the key clinical features, multimodality imaging findings, and diagnostic red flags needed to distinguish true hypertrophic cardiomyopathy from its various phenocopies.
Hypertrophic cardiomyopathy (HCM) is an inherited myocardial disease defined by unexplained thickening and hypertrophy of ventricular myocardium. However, several other conditions-"phenocopies" or mimics-can present with a similar hypertrophic phenotype. This article details the major HCM phenocopies, including infiltrative and storage diseases (amyloidosis, Fabry, Pompe, and Danon), systemic granulomatous disease (sarcoidosis), mitochondrial disorders, physiologic hypertrophy (athlete's heart), and hypertensive heart disease and aortic stenosis. We describe their distinguishing clinical features, multimodality imaging findings, pathophysiology, and key diagnostic clues highlighting red-flag signs and recent advances in diagnostics.
No takes yet. Share an insight, caveat, or question.
Son et al. (2026) conducted a review in Hypertrophic cardiomyopathy (HCM) and its phenocopies. Multimodality imaging and clinical red-flag clues differentiate hypertrophic cardiomyopathy from its infiltrative, storage, granulomatous, mitochondrial, and physiologic phenocopies.
Synapse has enriched 10 related papers. Consider them for comparative context: